To verify the functions of activated BCAA metabolism in NSCLC brain metastases, we knocked down BCAT1 using shRNA in A549 and H1229 cells, and verified by qRT-PCR and western-blot (Fig. 4A, B). This evidence concerns the gene BCAT1 and non-small cell lung carcinoma.